A comprehensive analysis of clinical trials in pancreatic cancer: what is coming down the pike?

Objective: Pancreatic cancer is the most aggressive common cancer and is desperately in need of novel therapies. Unlike many other common cancers, there have been no new paradigm-changing therapies in the past 40 years beyond multi-agent chemotherapy. In this study, we perform the first comprehensiv...

Descripción completa

Detalles Bibliográficos
Autores principales: Katayama, Erryk S., Hue, Jonathan J., Bajor, David L., Ocuin, Lee M., Ammori, John B., Hardacre, Jeffrey M., Winter, Jordan M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2020
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7517959/
https://www.ncbi.nlm.nih.gov/pubmed/33014285
http://dx.doi.org/10.18632/oncotarget.27727

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7517959/
https://www.ncbi.nlm.nih.gov/pubmed/33014285
http://dx.doi.org/10.18632/oncotarget.27727

Ejemplares similares